ReviewFrontiers in oncology2025

High-risk neuroblastoma in Mexico: from multimodal treatment to immunotherapy. Regarding the first case treated with naxitamab.

Alberto Olaya Vargas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.